Company: LCTX
Filing Date: 2025-08-15
Form Type: S-8
Source: 0000950170-25-109396
Chunk: 2

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-08-15
Form: S-8
Chunk 2
---
 the Securities Act.

<div align='center'>2</div>

PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

| Item 8. | Exhibits |

The following exhibits are filed as a part of or incorporated by reference into this Registration Statement:

|             |                                                                                                                                                    |                     |                     | Incorporated by Reference |            |          |     |         |     |             |     |                |
| Exhibit No. |                                                                                                                                                    | Exhibit Description |                     |                      Form |            | File No. |     | Exhibit |     | Filing Date |     | Filed Herewith |
| 5.1         | Opinion of Sheppard, Mullin, Richter & Hampton, LLP                                                                                                |                     |                     |                           |            | X        |     |         |     |             |     |                |
| 23.1        | Consent of Baker Tilly US, LLP                                                                                                                     |                     |                     |                           |            | X        |     |         |     |             |     |                |
| 23.2        | Consent of WithumSmith+Brown, PC                                                                                                                   |                     |                     |                           |            | X        |     |         |     |             |     |                |
| 23.3        | Consent of Sheppard, Mullin, Richter & Hampton, LLP (included in Exhibit 5.1)                                                                      |                     |                     |                           |            | X        |     |         |     |             |     |                |
| 24.1        | Power of Attorney (contained on the signature page of this Registration Statement)                                                                 |                     |                     |                           |            | X        |     |         |     |             |     |                |
| 99.1(a)     | Lineage Cell Therapeutics, Inc. 2021 Equity Incentive Plan                                                                                         | 8-K                 | 001-12830-211254211 |                      10.1 | 09/15/2021 |          |     |         |     |             |     |                |
| 99.1(b)     | Amendment to the Lineage Cell Therapeutics, Inc. 2021 Equity Incentive Plan                                                                        | 8-K                 | 001-12830-231242967 |                      10.1 | 09/06/2023 |          |     |         |     |             |     |                |
| 99.1(c)     | Amendment No. 2 to the Lineage Cell